Aridis Pharmaceuticals, Inc. Skyrocketed
Fri, Jul 29, 2022 at 06:58 PM
Aridis Pharmaceuticals, Inc. (ARDS:NASDAQ) jumped higher at $2.47, representing a gain of 28.6%. On Fri, Jul 29, 2022, ARDS:NASDAQ hit a New 2-Week High of $2.47. The stock appeared on our News Catalysts scanner on Fri, Jul 01, 2022 at 02:18 PM in the 'BIOTECH' category. From Fri, Jul 15, 2022, the stock recorded 80.00% Up Days and 45.45% Green Days
The stock spiked on Thu, Feb 17, 2022 at $2.94 with a volume of 3M+.
About Aridis Pharmaceuticals, Inc. (ARDS:NASDAQ)
Aridis Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is engaged in the discovery and development of targeted immunotherapy using fully human monoclonal antibodies, or mAbs, to treat life-threatening infections.
Top 10 Gainers:
- Getty Images Holdings Inc. Class A (GETY:NYSE), 149.05%
- AMTD Digital Inc. American Depositary Shares (every five of which represent two Class A) (HKD:NYSE), 122.36%
- Senti Biosciences Inc Com (SNTI:NASDAQ), 68.28%
- NRX Pharmaceuticals Inc. (NRXP:NASDAQ), 51.57%
- Meihua International Medical Technologies Co. Ltd. (MHUA:NASDAQ), 40.24%
- Pagaya Technologies Ltd. (PGY:NASDAQ), 38.12%
- Aridis Pharmaceuticals, Inc. (ARDS:NASDAQ), 28.65%
- ThermoGenesis Holdings, Inc. (THMO:NASDAQ), 26.96%
- Regional Health Properties, Inc. (RHE:NYSEMKT), 26.76%
- AXT, Inc. (AXTI:NASDAQ), 24.93%